Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, July 8, 2026

Neuroplasticity-Driven Rehabilitation Strategies in Disability-Related Locomotor Disorders: A ClinicalTrials.gov-Based Analysis

 

Completely useless; they know ABSOLUTELY NOTHING THAT WILL GUARANTEE NEUROPLASTICITY!

You haven't identified the EXACT signals between neurons that tells one neuron to drop their use and take on a neighboring neuron's use! That could then make neuroplasticity repeatable on demand.  Until that occurs ALL OF THIS SUPPOSED NEUROPLASTICITY RESEARCH IS ALMOST COMPLETELY FUCKING USELESS! 

Neuroplasticity-Driven Rehabilitation Strategies in Disability-Related Locomotor Disorders: A ClinicalTrials.gov-Based Analysis


Abstract

Locomotor disorders comprise a broad spectrum of neurological and musculoskeletal conditions that impair gait, mobility, balance, and functional independence. Conditions such as osteoarthritis, spinal cord injury, stroke-related disability, ligament injuries, fractures, muscular strains, and neurodegenerative diseases contribute substantially to global disability and reduced quality of life. Increasing interest has emerged in neuroplasticity-driven rehabilitation strategies, including device-based rehabilitation, neuromodulation technologies, exercise-based therapies, and pharmacological interventions aimed at restoring locomotor function. This study aimed to systematically analyze completed interventional clinical trials related to locomotor disorders registered on ClinicalTrials.gov. A retrospective registry-based descriptive analysis was conducted using ClinicalTrials.gov. The database was searched on 14 May 2026 using the keywords “locomotor,” with filters applied for completed interventional studies. Extracted variables included intervention type, study design, enrollment size, participant characteristics, outcome measures, and study phase. A total of 70 completed interventional trials were included. Device-based interventions represented the largest proportion of studies, followed by rehabilitation-based and behavioral interventions, while pharmacological studies were limited. Most trials enrolled fewer than 100 participants and primarily assessed mobility and functional performance outcomes. Safety and quality-of-life outcomes were infrequently reported. Neuromodulation approaches, including functional electrical stimulation and wearable rehabilitation technologies, demonstrated increasing representation within the identified studies, reflecting growing interest in neuroplasticity-based rehabilitation. However, substantial heterogeneity in study design and outcome reporting was observed across trials. Overall, the findings demonstrate that locomotor rehabilitation research is increasingly focused on technology-assisted and neuroplasticity-oriented interventions, although limitations related to small sample sizes, inconsistent outcome measures, and limited long-term evaluation remain significant barriers to clinical translation. Future large-scale multicenter trials with standardized methodological frameworks are needed to strengthen evidence-based rehabilitation strategies for locomotor disorders.

Main article text

No comments:

Post a Comment